LH receptor gene mutations and polymorphisms: an overview.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular and Cellular Endocrinology

• Publication date

  2007-01-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MCE.2005.11.048PMID 17030087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List

  2005cited by this paper
• Mutations in human gonadotropin and gonadotropin-receptor genes

  2005cited by this paper
• An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms.

  2005cited by this paper
• Structure of human follicle-stimulating hormone in complex with its receptor

  2005cited by this paper
• Leydig cell hypoplasia: absent luteinizing hormone receptor cell surface expression caused by a novel homozygous mutation in the extracellular domain.

  2004cited by this paper
• Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism.

  2003cited by this paper
• Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action.

  2003cited by this paper
• Luteinizing hormone signaling and breast cancer: polymorphisms and age of onset.

  2003cited by this paper
• The lutropin/choriogonadotropin receptor, a 2002 perspective.

  2002cited by this paper
• Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene

  2002cited by this paper
• Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: abnormal processing causes signaling deficiency.

  2002cited by this paper
• Mutational analysis of the luteinizing hormone receptor gene in two individuals with Leydig cell tumors.

  2002cited by this paper
• Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor.

  2002cited by this paper
• Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice.

  2001cited by this paper
• Estrogen and the risk of breast cancer.

  2001cited by this paper
• Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene.

  2001cited by this paper
• Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function.

  2000cited by this paper
• A novel luteinizing hormone receptor mutation in a patient with familial male-limited precocious puberty: effect of the size of a critical amino acid on receptor activity.

  1999cited by this paper
• Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor.

  1999cited by this paper
• Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia.

  1998cited by this paper
• Evidences for an allelic variant of the human LC/CG receptor rather than a gene duplication: functional comparison of wild-type and variant receptors.

  1998cited by this paper
• Severe testotoxicosis phenotype associated with Asp578-->Tyr mutation of the lutrophin/choriogonadotrophin receptor gene.

  1998cited by this paper
• A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype.

  1998cited by this paper
• An Inactivating Mutation of the Luteinizing Hormone Receptor Causes Amenorrhea in a 46,XX Female*

  1996cited by this paper
• A case of male-limited precocious puberty caused by a point mutation in the second transmembrane domain of the luteinizing hormone choriogonadotropin receptor gene.

  1996cited by this paper
• Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia.

  1996cited by this paper
• Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene.

  1996cited by this paper
• Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling.

  1996cited by this paper
• An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female.

  1996cited by this paper
• Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor--a clinical research center study.

  1996cited by this paper
• Testicular and Ovarian Resistance to Luteinizing Hormone Caused by Inactivating Mutations of the Luteinizing Hormone–Receptor Gene

  1996cited by this paper
• Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty.

  1995cited by this paper
• Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene

  1995cited by this paper
• A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty

  1993cited by this paper
• Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty.

  1993cited by this paper
• Cloning and sequencing of human LH/hCG receptor cDNA.

  1990cited by this paper
• Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family.

  1989cited by this paper
• Cloning and sequencing of porcine LH-hCG receptor cDNA: variants lacking transmembrane domain.

  1989cited by this paper
• Male-limited familial precocious puberty in three generations. Apparent Leydig-cell autonomy and elevated glycoprotein hormone alpha subunit.

  1984cited by this paper
• Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases.

  1983cited by this paper

• A comprehensive review of the new FIGO classification of ovulatory disorders.

  2024cites this paper
• Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Infertility Due to Premature Ovarian Failure

  2022cites this paper
• Gonadotropin receptor polymorphisms (FSHR N680S and LHCGR N312S) are not predictive of clinical outcome and live birth in assisted reproductive technology.

  2022cites this paper
• Physiologie der Hodenfunktion

  2021cites this paper
• Suboptimal response to GnRH agonist trigger: causes and practical management

  2021cites this paper
• Receptors | Thyroid-Stimulating Hormone/Luteinizing Hormone/Follicle-Stimulating Hormone Receptors

  2020cites this paper
• Diseases caused by mutations in luteinizing hormone/chorionic gonadotropin receptor.

  2019cites this paper
• of Testicular Function

  2018cites this paper
• The gonadotropin system, lessons from animal models and clinical cases.

  2018cites this paper
• Empty Follicular Syndrome: Understanding Controversial Entity

  2017cites this paper
• The Physiology of the Testis

  2016cites this paper
• Misfolding Ectodomain Mutations of the Lutropin Receptor Increase Efficacy of Hormone Stimulation.

  2016cites this paper
• Dissecting the structural and functional features of the Luteinizing hormone receptor using receptor specific single chain fragment variables.

  2016cites this paper
• Towards a non-animal risk assessment for anti-androgenic effects in humans.

  2015cites this paper
• Control of the Menstrual Cycle

  2015cites this paper
• Functional genomics of PCOS: from GWAS to molecular mechanisms.

  2015cites this paper
• Molecular genetics of polycystic ovary syndrome: an update.

  2015cites this paper
• Hormones and Growth Factors Used Therapeutically

  2015cites this paper
• Empty follicle syndrome after GnRH agonist triggering: Is it possible to res- cue with hCG? Two cases and review of the literature

  2015cites this paper
• Comparison of FSH Receptor Polymorphisms Between Infertile andFertile Women

  2014cites this paper
• Chapter 2 – The Gonadotropin Hormones and Their Receptors∗

  2014cites this paper
• Endocrine disorders in the neonatal period.

  2013cites this paper
• Structural and functional plasticity of the luteinizing hormone/choriogonadotrophin receptor.

  2013cites this paper
• Structure, function and regulation of gonadotropin receptors - a perspective.

  2012influential citation
• Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS

  2012cites this paper
• Regulatory processes governing the cell surface expression of LH and FSH receptors.

  2012cites this paper
• The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7‐fold increased risk of polycystic ovary syndrome in a Sardinian population

  2012cites this paper
• Genetic aspects of premature ovarian failure: a literature review

  2011cites this paper
• Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism.

  2011cites this paper
• Combination of polymorphisms in luteinizing hormone β, estrogen receptor β and progesterone receptor and susceptibility to infertility and endometriosis.

  2011cites this paper
• Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function

  2011cites this paper
• Application of the New Classification on Patients with a Disorder of Sex Development in Indonesia

  2011cites this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cites this paper
• Luteinizing hormone beta-subunit gene (LHbeta) polymorphism in infertility and endometriosis-associated infertility.

  2010cites this paper
• Pharmacological Chaperones: Potential for the Treatment of Hereditary Diseases Caused by Mutations in G Protein‐Coupled Receptors

  2010cites this paper
• Best Practice & Research Clinical Obstetrics and Gynaecology

  2010cites this paper
• Physiology of Testicular Function

  2010cites this paper
• Bicalutamide and Third-Generation Aromatase Inhibitors in Testotoxicosis

  2010cites this paper
• Steroidogenic factor-1 (SF-1) gene mutation as a frequent cause of primary amenorrhea in 46,XY female adolescents with low testosterone concentration

  2010cites this paper
• The XY female.

  2010cites this paper
• Guide to Receptors and Channels (GRAC), 4th edition

  2009cites this paper
• Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism.

  2009cites this paper
• Hypothalamic-Pituitary-Gonadal Axis in Men

  2009cites this paper
• Determining the affinity of hormone-receptor interaction.

  2009cites this paper
• The Gonadotropin Hormones and Their Receptors

  2009cites this paper
• Activation of the lutropin/choriogonadotropin receptor inhibits apoptosis of immature Leydig cells in primary culture.

  2009cites this paper
• Diseases associated with mutations of the human lutropin receptor.

  2009cites this paper
• CHAPTER 16 – The Testes: Disorders of Sexual Differentiation and Puberty in the Male

  2008cites this paper
• Allosteric modulators of glycoprotein hormone receptors: discovery and therapeutic potential

  2008cites this paper
• 7TM Receptors

  2008cites this paper
• G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo

  2007cites this paper
• Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancer.

  2007cites this paper
• The Role of the Hypothalamus-Pituitary-Gonadal Axis in Breast Cancer: a candidate gene approach

  2007cites this paper